The Rotem system uses Thromboelastometric analysis to provide a quantitative and qualitative indication of the coagulation state of a blood sample that can detect clot formation and firmness as well as clot lysis.
Coagulation evaluations with the ROTEM® delta are commonly used to assess clinical conditions in organ transplantation, cardiovascular surgery, cardiology procedures and trauma to assess post-operative hemorrhage and/or thrombosis.
Interpretive report provided.
ROTEM viscoelastic testing is not FDA approved for the pediatric population (<21 years of age) and the attached reference ranges pertain to adults only.
Patients with hypofibrinogenemia have not been fully evaluated.
- Dysfibrinogenemic patients were not tested.
Typically 30 minutes. Analytic time can be physician determined for individual cases.
24 hours daily
This test is available only to University of Michigan registered patients.
Specimen must be kept at room temperature and walked directly to the Hematology/Coagulation laboratory, Main Hospital, Room 2F360, along with the completed requisition.
Physicians should complete Rotem result interpretation training in MLearning code PATH-62077 prior to ordering this test. Results are viewable as a scanned document in MiChart under Chart Review, Labs, Rotem Graphic Result. To access Citrix Remote Viewing for ROTEM via the kioske PCs located in most patient care areas:
All UMHS domain users can access the application from https://vplaces.med.umich.edu using their level 2 credentials from any core system.
On Non-Kiosk Core Systems it can be accessed by either https://vplaces.med.umich.edu or via the Start menu.
- The Start menu option is not available for Kiosk systems.
Log in with Level 2 password.
You will see the Citrix applications including ROTEM.
You will be paged from the lab as to which remote ROTEM to view.
Click on the appropriate ROTEM viewer.
Remote access password: rotemremote
Result report will be scanned in Mi-Chart by the Lab and can be viewed at Chart Review -> Labs -> ROTEM Graphic Result.